Optimizing Oral Controlled Release Drug Delivery Systems using Experimental Designs

The number of literature reports on the use of design of experiments optimization in development of drug delivery technology has been piling up steadily. This review article provides an updated bird’s eye view survey account on the publications and optimization techniques of different novel controlled release delivery designs for use in oral applications. Such systematic techniques find their use in every type of conventional dosage form and novel drug delivery system. The drug delivery devices investigated for optimization using various designs include oral controlled release tablet. The present manuscript deal with various steps involved in design of experiments optimization methodology using diverse experimental designs. It also deals with a variety of showing literature findings as well as the potential application of such design of experiments procedures on optimization of assorted drug delivery systems. Such an explicit and updated review on drug delivery optimization has not been published anywhere else in the recent past.

[1]  T Nagai,et al.  Formulation optimization of sustained-release tablet of chlorpheniramine maleate by means of extreme vertices design and simultaneous optimization technique. , 1992, Chemical & pharmaceutical bulletin.

[2]  A Puech,et al.  THE ROLE OF GELUCIRE IN THE AVAILABILITY OF THEOPHYLLINE IN SEMISOLID MATRIX CAPSULES. A STUDY OF THE FACTORS : PH, MELTING POINT, H.L.B. AND PADDLE R OTATION SPEED , 1991 .

[3]  Lukchiu Li,et al.  In Vitro Drug Release from Matrix Tablets Containing a Silicone Elastomer Latex , 1991 .

[4]  H. Lennernäs,et al.  Oral Drug Absorption: Prediction and Assessment , 2000 .

[5]  S. Leucuţa,et al.  Optimization of hydrophilic matrix tablets using a D-optimal design , 1997 .

[6]  H. Zia,et al.  Formulation and Optimization of a Sustained-Release Tablet of Ketorolac Tromethamine , 2002, Drug delivery.

[7]  P. Tyle.  Controlled drug delivery: Fundamentals and applications , 1988 .

[8]  M. Gohel,et al.  Development of Modified Release Diltiazem HCl Tablets Using Composite Index to Identify Optimal Formulation , 2003, Drug development and industrial pharmacy.

[9]  J. C. Price,et al.  Optimization of sustained-release tablet formulations: a four-component mixture experiment. , 1997, Pharmaceutical development and technology.

[10]  M. Panchal,et al.  Modulation of Drug Release Rate of Diltiazem–HCl from Hydrogel Matrices of Succinic Acid-Treated Ispaghula Husk , 2000, Pharmaceutical development and technology.

[11]  Angel Concheiro,et al.  Mechanical and drug-release properties of atenolol-Carbomer hydrophilic matrix tablets , 1991 .

[12]  Sanford Bolton,et al.  Controlled release coprecipitates : formulation considerations , 1995 .

[13]  U. Jáuregui-Haza,et al.  Statistical Optimization of a Sustained-Release Matrix Tablet of Lobenzarit Disodium , 2000, Drug development and industrial pharmacy.

[14]  Mukesh C. Gohel,et al.  Application Of Simplex Lattice Design To The Preparation Of Sustained-Release Diltiazem Hydrochloride Tablets Using Modified Guar Gum , 1999 .

[15]  Robert D. Johnson,et al.  Application of Neural Computing in Pharmaceutical Product Development , 1991, Pharmaceutical Research.

[16]  J. M. Suñé-Negre,et al.  Study of Formulation Parameters by Factorial Design in Metoprolol Tartrate Matrix Systems , 2001, Drug development and industrial pharmacy.

[17]  L. J. Lucisano,et al.  In vitro evaluation of a mixed polymeric sustained release matrix using response surface methodology , 1987 .

[18]  Ravi Kumar M.N.V..  Nano and microparticles as controlled drug delivery devices. , 2000 .

[19]  B. Müller,et al.  Optimization of the amount of xanthan gum and guar gum in a matrix tablet formulation using a central composite design , 1992 .

[20]  A S Hussain,et al.  Identification of critical formulation and processing variables for metoprolol tartrate extended-release (ER) matrix tablets. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[21]  Mukesh C. Gohel,et al.  Optimization of Hydrophilic Matrix Tablet Formulation of Diclofenac Sodium using a Mixture Design , 1998 .

[22]  J. Parojčić,et al.  Artificial neural networks in the modeling and optimization of aspirin extended release tablets with eudragit L 100 as matrix substance , 2008, AAPS PharmSciTech.

[23]  M. A. Khan,et al.  Response surface methodology to obtain naproxen controlled release tablets from its microspheres with Eudragit L100-55. , 2001, Journal of microencapsulation.

[24]  G. Peck,et al.  Water based silicone elastomer controlled release tablet film coating V - A statistical approach , 1991 .

[25]  R Fisher,et al.  Design of Experiments , 1936 .

[26]  Sunil P. Shah,et al.  Development of Misoprostol 3-Hour Controlled Release Formulations Using Response Surface Methodology , 1992 .

[27]  M. Gohel,et al.  FORMULATION OPTIMIZATION OF DILTIAZEM HCL MATRIX TABLETS CONTAINING MODIFIED GUAR GUM USING A CENTRAL COMPOSITE DESIGN , 1999 .

[28]  G. A. Lewis,et al.  NON CLASSICAL EXPERIMENTAL DESIGNS IN PHARMACEUTICAL FORMULATION , 1991 .

[29]  Sandra Furlanetto,et al.  Didanosine extended-release matrix tablets: optimization of formulation variables using statistical experimental design. , 2002, International journal of pharmaceutics.

[30]  Rihard Karba,et al.  Mixture design of theophylline retard formulation , 1993 .

[31]  A. Sakr,et al.  Application of multiple-response optimization to fluoride release from an extended-release matrix tablet , 2004 .

[32]  Kozo Takayama,et al.  Computer optimization for the formulation of controlled-release theophylline tablet made of micronized low-substituted hydroxypropylcellulose and methylcellulose , 1994 .

[33]  G. Ritthidej,et al.  Development of Diclofenac Sodium Controlled Release Solid Dispersion Tablet Using Optimization Strategy , 1997 .

[34]  J. D. Watt,et al.  The Effect of Processing Variables on the Release of Ibuprofen and Caffeine from Controlled-Release Nonswellable Core-in-Cup Compressed Tablets , 1996 .

[35]  D. Chulia,et al.  [Statistical optimization of sustained-release preparations of sodium diclofenac in the form of inert matrices. I]. , 1988, Pharmaceutica acta Helvetiae.

[36]  Joseph B. Schwartz,et al.  Optimization of a Slow-Release Tablet Formulation Containing Sodium Sulfathiazole and a Montmorillonite Clay , 1985 .

[37]  Jelena Parojčić,et al.  An Investigation into the Factors Influencing Drug Release from Hydrophilic Matrix Tablets Based on Novel Carbomer Polymers , 2004, Drug delivery.

[38]  P Timmins,et al.  Optimization and characterization of a pH-independent extended-release hydrophilic matrix tablet. , 1997, Pharmaceutical development and technology.

[39]  S. A. Sande,et al.  Development of pectin matrix tablets for colonic delivery of model drug ropivacaine. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[40]  M. Gohel,et al.  Formulation Optimization of Diltiazem Hydrochloride Matrix Tablets Containing Modified Ispaghula Husk Using Factorial Design , 1997 .

[41]  B. Müller,et al.  Optimization of a matrix tablet formulation using a mixture design. , 1992, Acta pharmaceutica Nordica.

[42]  G. Peck,et al.  Water Based Silicone Elastomer Controlled Release Tablet Film Coating IV Process Evaluation , 1988 .

[43]  R. Fassihi,et al.  Application of response surface methodology to design optimization in formulation of a typical controlled release system , 1995 .

[44]  J. Fredrickson,et al.  A mixture experiment approach for controlling the dissolution rate of a sustained-release tablet. , 1998, Drug development and industrial pharmacy.

[45]  Bhupinder Singh,et al.  Optimizing drug delivery systems using systematic "design of experiments." Part II: retrospect and prospects. , 2005, Critical reviews in therapeutic drug carrier systems.

[46]  M. Khan,et al.  Statistical Optimization of Ketoprofen-Eudragit® S100 Coprecipitates to Obtain Controlled-Release Tablets , 1996 .

[47]  Mounir S. Mesiha,et al.  Factorial Design of Phenylpropanolamine Prolonged Release Tablets Formulations Using Fluid Bed Dryer Granulator , 1994 .

[48]  Kozo Takayama,et al.  Multi-objective simultaneous optimization technique based on an artificial neural network in sustained release formulations , 1997 .

[49]  C Caramella,et al.  On the employment of lambda carrageenan in a matrix system. III. Optimization of a lambda carrageenan-HPMC hydrophilic matrix. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[50]  Svetlana Ibrić,et al.  The application of generalized regression neural network in the modeling and optimization of aspirin extended release tablets with Eudragit RS PO as matrix substance. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[51]  Sheng Hai.  APPLICATION OF ARTIFICAL NEURAL NETWORKS FOR FORMULATION DESIGNING OF MATRIX TABLETS , 1998 .